qaialdo
nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.
candesartan krka 4 mg
krka sverige ab - kandesartancileksetil - tablett - 4 mg
candesartan krka 8 mg
krka sverige ab - kandesartancileksetil - tablett - 8 mg
candesartan krka 16 mg
krka sverige ab - kandesartancileksetil - tablett - 16 mg
candesartan krka 32 mg
krka sverige ab - kandesartancileksetil - tablett - 32 mg
cozaar 2.5 mg/ ml
merck sharp & dohme b.v. - losartankalium - pulver og væske til mikstur, suspensjon - 2.5 mg/ ml
cozaar 12.5 mg
merck sharp & dohme b.v. - losartankalium - tablett, filmdrasjert - 12.5 mg
cozaar comp 50 mg / 12.5 mg
n.v. organon - kloosterstraat - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg
cozaar comp 100 mg / 12.5 mg
n.v. organon - kloosterstraat - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg
cozaar comp forte 100 mg / 25 mg
n.v. organon - kloosterstraat - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 25 mg